FindTrial
Sign In

OncAlert

DEVICE2 trials

Sponsors

Joseph Califano, Vigilant Biosciences, Inc.

Conditions

Gingival NeoplasmsLeukoplakia, OralLip NeoplasmOral Cavity Squamous Cell CarcinomaOral UlcerOropharyngeal NeoplasmsOropharynx Squamous Cell CarcinomaPalatal Neoplasms

Unknown Phase

Saliva-based Detection of CD44
CompletedNCT03148665
Joseph CalifanoOral Cavity Squamous Cell Carcinoma, Oropharynx Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck +1
Start: 2017-04-14End: 2022-05-03Updated: 2022-08-17
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
CompletedNCT03239834
Vigilant Biosciences, Inc.Gingival Neoplasms, Leukoplakia, Oral, Lip Neoplasm +4
Start: 2017-09-07End: 2020-12-20Updated: 2021-08-12

Related Papers

Salivary CD44 and Total Protein Levels to Detect Risk for Oral and Oropharyngeal Cancer Recurrence
JAMA Otolaryngology–Head & Neck Surgery2024-08-157 citations